Interview with Dr. John R. Thornback, Chief Executive Officer, Dx assays
Nine months ago you were appointed CEO of the company. What brought you to Dx assays? I think Dx Assays is a very interesting opportunity, which is why I came…
Address: Unit #02-01/02/03, Blk 35 Marsiling Ind Estate Road 3, Woodlands Central Industrial Estate, Singapore 739257,Singapore
Tel: +65 6499 0720
Dx assays mission is to provide high-quality molecular assay development and assay validation to their customers with speed and efficiency, coupled with their fee-for-service and co-development business model, Dx assays focus on ‘delivering your success’.
Their laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel according to CE and FDA requirements. They provide fully ISO 9001 and ISO 13485 accredited processes and procedures which gives its clients a guarantee of high quality product development and documentation that meets regulatory requirements
Dx assays provide advanced molecular diagnostic assay development, verification, validation, and high quality product enhancement services. They have a proven track record and have delivered successful projects to a wide variety of pharmaceutical, clinical and diagnostic customers all around the world.
Nine months ago you were appointed CEO of the company. What brought you to Dx assays? I think Dx Assays is a very interesting opportunity, which is why I came…
Martin Dewhurst of the Global Pharmaceuticals and Medical Products Practice at McKinsey & Company provides his view of the Asia Pacific Medtech Forum 2016 in Singapore and elaborates on the…
Boehringer Ingelheim’s (BI) country managing director in South East Asia and South Korea (SEASK), Gerrard McKenna characterizes the recent changes within the family-owned business as “evolutionary” in nature, while highlighting…
Philips general manager of Health Systems, South East Asia, Johan Vooren highlights the company’s renewed commitment to Singapore with the recent opening of their APAC Center, while detailing the qualities…
Takeda’s President of Emerging Markets Business Unit, Giles Platford, speaks about his assignments across various global markets, his leadership philosophy, as well as the impressive international growth of the company.…
Eli Lilly and Company General Manager of South ASEAN, Dr. Faiz Ansari speaks about the expanded scope of his role, Lilly’s pipeline, and the approach that Lilly has taken to…
In an exclusive interview with Alan Ong, Executive Vice President of Asia Pacific and Global Head of Medical Devices and Diagnostics at INC Research, he highlights the current trends facing…
In an exclusive interview with Stephen Ooi, Senior Executive Advisor at Zimmer Biomet, he emphasizes the strategic benefits of the global merger between Zimmer and Biomet and how through leveraging…
In an interview with Takeda’s President of Emerging Markets Business Unit, Giles Platford portrays a vitalized focus on emerging markets and explains why those countries are positioned as one of…
Cerner’s managing director of Southeast Asia, Rebecca LaNasa highlights the key importance that Singapore—as the company’s third office outside the U.S.—serves in implementing and piloting new forms of health care…
Recently appointed Senior Vice President of Asia Pacific, Massimiliano Colella speaks about Smith & Nephew’s reasons for establishing a presence in the region, their dual approach in catering to the…
DB Schenker’s director of healthcare in Asia Pacific, Sugantha Natarajan describes the company’s presence across the region, while emphasizing the crucial need for localized solutions in specialized healthcare logistics. She…
In an exclusive interview with Richard Saynor at GSK, he outlines the growth of the CEP portfolio in emerging markets and highlights the opportunities and challenges in the region, as…
See our Cookie Privacy Policy Here
